BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28275775)

  • 1. History of EPI Suite™ and future perspectives on chemical property estimation in US Toxic Substances Control Act new chemical risk assessments.
    Card ML; Gomez-Alvarez V; Lee WH; Lynch DG; Orentas NS; Lee MT; Wong EM; Boethling RS
    Environ Sci Process Impacts; 2017 Mar; 19(3):203-212. PubMed ID: 28275775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case.
    Ortiz de García S; Pinto GP; García-Encina PA; Irusta Mata RI
    J Environ Manage; 2013 Nov; 129():384-97. PubMed ID: 23995140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of action and the assessment of chemical hazards in the presence of limited data: use of structure-activity relationships (SAR) under TSCA, Section 5.
    Auer CM; Nabholz JV; Baetcke KP
    Environ Health Perspect; 1990 Jul; 87():183-97. PubMed ID: 2269224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The unsteady state and inertia of chemical regulation under the US Toxic Substances Control Act.
    Krimsky S
    PLoS Biol; 2017 Dec; 15(12):e2002404. PubMed ID: 29252997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving substance information in USEtox
    Saouter E; Aschberger K; Fantke P; Hauschild MZ; Kienzler A; Paini A; Pant R; Radovnikovic A; Secchi M; Sala S
    Environ Toxicol Chem; 2017 Dec; 36(12):3463-3470. PubMed ID: 28671290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new chemicals process at the Environmental Protection Agency (EPA): structure-activity relationships for hazard identification and risk assessment.
    Wagner PM; Nabholz JV; Kent RJ
    Toxicol Lett; 1995 Sep; 79(1-3):67-73. PubMed ID: 7570675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population susceptibility: A vital consideration in chemical risk evaluation under the Lautenberg Toxic Substances Control Act.
    Koman PD; Singla V; Lam J; Woodruff TJ
    PLoS Biol; 2019 Aug; 17(8):e3000372. PubMed ID: 31465433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Science and regulation. New science for chemicals policy.
    Schwarzman MR; Wilson MP
    Science; 2009 Nov; 326(5956):1065-6. PubMed ID: 19965413
    [No Abstract]   [Full Text] [Related]  

  • 10. (Q)SARs to predict environmental toxicities: current status and future needs.
    Cronin MT
    Environ Sci Process Impacts; 2017 Mar; 19(3):213-220. PubMed ID: 28243641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixture toxicity, cumulative risk, and environmental justice in United States federal policy, 1980-2016 : Why, with much known, was little done?
    Sprinkle RH; Payne-Sturges DC
    Environ Health; 2021 Sep; 20(1):104. PubMed ID: 34535123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rethink how chemical hazards are tested.
    Warner JC; Ludwig JK
    Nature; 2016 Aug; 536(7616):269-70. PubMed ID: 27535519
    [No Abstract]   [Full Text] [Related]  

  • 13. U.S. EPA regulatory perspectives on the use of QSAR for new and existing chemical evaluations.
    Zeeman M; Auer CM; Clements RG; Nabholz JV; Boethling RS
    SAR QSAR Environ Res; 1995; 3(3):179-201. PubMed ID: 8564854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of dermal exposure assessment in the US Environmental Protection Agency Toxic Substances Control Act risk evaluations of chemical manufacturing.
    Lynch HN; Gloekler LE; Allen LH; Maskrey JR; Bevan C; Maier A
    Toxicol Ind Health; 2023 Jan; 39(1):49-65. PubMed ID: 36420912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of existing chemicals under TSCA: information disclosure as the route to reducing risk and increasing available data.
    Rosenthal I; Weiler ED; Keener RL; Cumberland PJ
    Qual Assur; 1992 Feb; 1(2):89-96. PubMed ID: 1344214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why the toxic substances control act needs an overhaul, and how to strengthen oversight of chemicals in the interim.
    Vogel SA; Roberts JA
    Health Aff (Millwood); 2011 May; 30(5):898-905. PubMed ID: 21555473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Property Estimation of Per- and Polyfluoroalkyl Substances: A Comparative Assessment of Estimation Methods.
    Lampic A; Parnis JM
    Environ Toxicol Chem; 2020 Apr; 39(4):775-786. PubMed ID: 32022323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human health and the environment can't wait for reform: current opportunities for the federal government and states to address chemical risks under the Toxic Substances Control Act.
    Trevisan L
    Am Univ Law Rev; 2011; 61(2):385-430. PubMed ID: 25335197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updating the Toxic Substances Control Act to Protect Human Health.
    Trasande L
    JAMA; 2016 Apr; 315(15):1565-6. PubMed ID: 26974705
    [No Abstract]   [Full Text] [Related]  

  • 20. QSAR modeling of cumulative environmental end-points for the prioritization of hazardous chemicals.
    Gramatica P; Papa E; Sangion A
    Environ Sci Process Impacts; 2018 Jan; 20(1):38-47. PubMed ID: 29226926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.